EF
PCVX icon

Empowered Funds’s Vaxcyte PCVX Stock Holding History

Empowered Funds’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$315K Sell
5,424
-4,268
-44% -$232K ﹤0.01% 1852
2026
Q1 		$563K Buy
9,692
+5,116
+112% +$278K ﹤0.01% 1599
2025
Q4 		$211K Buy
+4,576
New +$205K ﹤0.01% 932

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Empowered Funds's PCVX Position: Q2 2026 in Review

Empowered Funds reduced its Vaxcyte (PCVX) stake by 44% in Q2 2026, selling an estimated $232K and leaving 5,424 shares worth $315K. The position accounts for ﹤0.01% of the portfolio, ranked #1852.

Empowered Funds first reported a position in PCVX in Q4 2025 and has held it in 3 quarters since. The position peaked at $563K in Q1 2026. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Empowered Funds held 5,424 shares of Vaxcyte worth $315K as of Q2 2026.
  • Empowered Funds sold 4,268 Vaxcyte shares in Q2 2026, an estimated $232K.
  • Vaxcyte made up ﹤0.01% of Empowered Funds's portfolio in Q2 2026, its #1852 holding.
  • Empowered Funds first reported a position in Vaxcyte in Q4 2025 and has held it in 3 quarters since.
  • Empowered Funds's Vaxcyte position peaked at $563K in Q1 2026.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.